BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18219287)

  • 1. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.
    Bhattacharyya M; Ryan D; Carpenter R; Vinnicombe S; Gallagher CJ
    Br J Cancer; 2008 Jan; 98(2):289-93. PubMed ID: 18219287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.
    Nakamura S; Kenjo H; Nishio T; Kazama T; Do O; Suzuki K
    Breast Cancer; 2001; 8(4):351-4. PubMed ID: 11791129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the indication for breast-conservative surgery (BCS) in patients with locally-advanced breast cancer.
    Mazilu L; Suceveanu AI; Tomescu D; Ciufu N; Baz R; Suceveanu AP; Parepa IR; Tofolean DE; Voinea F
    Chirurgia (Bucur); 2013; 108(4):478-81. PubMed ID: 23958089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and conservative treatment of locally advanced breast cancer.
    Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
    Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
    Denis F; Desbiez-Bourcier AV; Chapiron C; Arbion F; Body G; Brunereau L
    Eur J Surg Oncol; 2004 Dec; 30(10):1069-76. PubMed ID: 15522553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.
    Mazouni C; Naveau A; Kane A; Dunant A; Garbay JR; Leymarie N; Sarfati B; Delaloge S; Rimareix F
    Breast; 2013 Dec; 22(6):1189-93. PubMed ID: 24054903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
    Dose-Schwarz J; Tiling R; Avril-Sassen S; Mahner S; Lebeau A; Weber C; Schwaiger M; Jänicke F; Untch M; Avril N
    Br J Cancer; 2010 Jan; 102(1):35-41. PubMed ID: 19920815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer.
    Nicoletto MO; Nitti D; Pescarini L; Corbetti F; Mencarelli R; Cappetta A; Galligioni A; Pogliani C; Marchet A; Bozza F; Ghiotto C; Griggio L; Zavagno G; Donach ME; Di Maggio C
    Tumori; 2008; 94(4):481-8. PubMed ID: 18822682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery.
    Kaufmann P; Dauphine CE; Vargas MP; Burla ML; Isaac NM; Gonzalez KD; Rosing D; Vargas HI
    Am Surg; 2006 Oct; 72(10):935-8. PubMed ID: 17058739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
    Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome.
    Karanlik H; Ozgur I; Cabioglu N; Sen F; Erturk K; Kilic B; Onder S; Deniz M; Yavuz E; Aydiner A
    Eur J Surg Oncol; 2015 Sep; 41(9):1226-33. PubMed ID: 26141784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
    Straver ME; Loo CE; Rutgers EJ; Oldenburg HS; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
    Ann Surg; 2010 Apr; 251(4):701-7. PubMed ID: 20224378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary systemic therapy in breast cancer patients (2007-2010)].
    Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
    Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative second-line chemotherapy induces objective responses in primary breast cancer.
    Wenzel C; Locker GJ; Bartsch R; Pluschnig U; Hussian D; Zielinski CC; Rudas M; Gnant MF; Jakesz R; Steger GG
    Wien Klin Wochenschr; 2005 Jan; 117(1-2):48-52. PubMed ID: 15986591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.